Drug Search Results
More Filters [+]

DR-1021

Alternative Names: dr-1021, dr1021, dr 1021
Latest Update: 2021-11-18
Latest Update Note: Clinical Trial Update

Product Description

Oral Contraceptive (Sourced from: https://www.clinicaltrials.gov/ct2/show/NCT00544882)

Mechanisms of Action: Unknown

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Duramed Research
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for DR-1021

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Contraception|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

DR-DSG-302

P3

Completed

Healthy Volunteers

2008-03-31

DR-DSG-301

P3

Completed

Contraception

2007-07-01

Recent News Events

Date

Type

Title